Biotech Stock News (RXII)(REGN)(SNY)(ESPR)(ISIS)(BIIB)

Rxi Pharmaceuticals (NASDAQ:RXII) On June 9, 2015 shares of Rxi Pharmaceuticals went up 6% after the company reported that two new key patents were given to the company for use with their self-delivering sd-rxRNA technology platform. The new patents establish a few new details that enhance upon the company’s prospects: First the new patent is … Read more

Biotech Stock News (ISIS)(BAYRY)(ALXN)(GEVA)(LJPC)

Isis Pharmaceuticals (NASDAQ:ISIS) Shares of Isis were up 5% on May 4, 2015 after the company announced that Bayer AG (OTCMKTS:BAYRY) bought a license for an anti-clotting drug known as ISIS-FXRIx. This deal is more of a huge win for Isis as it continues to develop a multitude of RNA antisense drugs in many unmet … Read more

ISIS Pharmaceuticals Is Recovering From Market Wide Bloodshed

ISIS Pharmaceuticals, Inc. (NASDAQ: ISIS) ISIS Pharmaceuticals produced a great earnings report that was likely to excite investors yesterday. Unfortunately however we did see excitement, but it went in the wrong direction. Even after smashing earnings projections, ISIS Pharmaceuticals had a rough day in the market. However, today seems to be a bit of a … Read more

ISIS Pharmaceuticals (ISIS) Reports A Loss For Q1 | Beats Expectations

ISIS Pharmaceuticals, Inc. (NASDAQ: ISIS) As expected, ISIS Pharmaceuticals, Inc. reported their first quarter earnings before the open of the market today. Although the company did report a loss, the loss was more narrow than analysts expected. Today, we’ll talk about what we saw from the earnings report, how the market reacted to the news, … Read more

Why Stocks Are Falling So Hard Today

US stocks are down overall today for the third day in a row today; with today’s drop looking to be the steepest for many. Before the closing bell today, it was announced that orders for durable goods fell dramatically in the month of February; marking the third month out of the last four that we’ve … Read more